Cordlife Group Limited announced that it has entered into a Share Purchase Agreement with China Cord Blood Corporation ("CCBC"), to acquire 10% of the total issued share capital of CCBC for a total consideration of approximately $20.8 million. At the same time, Cordlife, through its wholly-owned subsidiary Cordlife (Hong Kong) Limited, has entered into a Shares Repurchase Agreement with China Stem Cells (South) Company Limited ("CSCS"), to sell to CSCS its 10% stake in CSCS through a repurchase of shares by CSCS. Upon completion of the transactions, Mr. Jeremy Yee will be appointed as non-executive director on CCBC's board of directors, and will step down as a director of CSCS.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | 0.00% |
|
+9.09% | -1.64% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-1.64% | 161M | |
+19.84% | 83.16B | |
-25.24% | 73.08B | |
-1.34% | 26.15B | |
+4.56% | 17.9B | |
-9.29% | 17.39B | |
+4.52% | 15.94B | |
+78.16% | 13.61B | |
+77.84% | 13.06B | |
-26.14% | 12.76B |
- Stock Market
- Equities
- CORBF Stock
- News Global Cord Blood Corporation
- China Cord Blood Corporation to Appoint Jeremy Yee as Non-Executive Director